| Article number | Proportion | 95% CI | τ2 | P |
---|---|---|---|---|---|
Age | Â | Â | Â | Â | 0.9317 |
>=18 | 4 | 0.0055 | [0.0022; 0.0140] | 0.8906 | Â |
< 18 | 2 | 0.0062 | [0.0007; 0.0554] | 2.5809 |  |
Reinfected variants | Â | Â | Â | Â | 0.0016 |
Wild | 7 | 0.0026 | [0.0010; 0.0066] | 1.3937 | Â |
Alpha | 2 | 0.0059 | [0.0043; 0.0082] | 0.0247 | Â |
Delta | 3 | 0.0041 | [0.0017; 0.0097] | 0.5690 | Â |
Omicron | 7 | 0.0410 | [0.0136; 0.1174] | 2.3479 | Â |
Country |  |  |  |  | < 0.0001 |
the United States | 15 | 0.00106 | [0.0051; 0.0222] | 2.1674 | Â |
the United Kingdom | 6 | 0.0048 | [0.0037; 0.0064] | 0.0819 | Â |
Türkiye | 3 | 0.0064 | [0.0015; 0.0266] | 1.6089 |  |
Italy | 4 | 0.0119 | [0.0033; 0.0416] | 1.6623 | Â |
India | 3 | 0.0297 | [0.0031; 0.2332] | 4.1048 | Â |
Iran | 2 | 0.0147 | [0.0043; 0.0490] | 0.7578 | Â |
Israel | 2 | 0.0147 | [0.0121; 0.0179] | 0.0196 | Â |
Spain | 3 | 0.0030 | [0.0005; 0.0160] | 2.1176 | Â |
Canada | 2 | 0.0136 | [0.0134; 0.0139] | 0 | Â |
Brazil | 2 | 0.0660 | [0.0394; 0.1084] | 0.1224 | Â |
Denmark | 2 | 0.0037 | [0.0034; 0.0039] | 0 | Â |
Study population | Â | Â | Â | Â | 0.1131 |
general population | 46 | 0.0081 | [0.0056; 0.0119] | 1.2939 | Â |
Healthcare workers | 9 | 0.0192 | [0.0071; 0.0508] | 1.5238 | Â |
Study type | Â | Â | Â | Â | 0.0020 |
cohort study | 46 | 0.0097 | [0.0064; 0.0147] | 2.0886 | Â |
case-control study | 6 | 0.0050 | [0.0030; 0.0084] | 0.3813 | Â |
cross-sectional study | 3 | 0.0213 | [0.0114; 0.0394] | 0.3128 | Â |